Jilin Jian Yisheng Pharmaceutical Balance Sheet Health
Financial Health criteria checks 4/6
Jilin Jian Yisheng Pharmaceutical has a total shareholder equity of CN¥2.3B and total debt of CN¥473.4M, which brings its debt-to-equity ratio to 20.4%. Its total assets and total liabilities are CN¥3.0B and CN¥688.7M respectively. Jilin Jian Yisheng Pharmaceutical's EBIT is CN¥41.4M making its interest coverage ratio -28.5. It has cash and short-term investments of CN¥542.2M.
Key information
20.4%
Debt to equity ratio
CN¥473.37m
Debt
| Interest coverage ratio | -28.5x |
| Cash | CN¥542.15m |
| Equity | CN¥2.32b |
| Total liabilities | CN¥688.69m |
| Total assets | CN¥3.00b |
Recent financial health updates
No updates
Financial Position Analysis
Short Term Liabilities: 002566's short term assets (CN¥2.4B) exceed its short term liabilities (CN¥418.6M).
Long Term Liabilities: 002566's short term assets (CN¥2.4B) exceed its long term liabilities (CN¥270.1M).
Debt to Equity History and Analysis
Debt Level: 002566 has more cash than its total debt.
Reducing Debt: 002566's debt to equity ratio has increased from 17.9% to 20.4% over the past 5 years.
Debt Coverage: 002566's debt is not well covered by operating cash flow (18.6%).
Interest Coverage: 002566 earns more interest than it pays, so coverage of interest payments is not a concern.